Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
NT 20-F
Form NT 20-F - Notification of inability to timely file Form 20-F
20-F
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
News
TYPE
HEADLINE
FILED AT
6-K
Alps Group Inc Announces Shareholder Approval for Share Consolidation, Share Capital Increase, and Adoption of Second Amended and Restated Memorandum and Articl
6-K
Alps Group Inc. Announces Postponement of Extraordinary General Meeting and Updated Virtual Participation Details
6-K
Alps Group Inc. Announces 2026 Extraordinary General Meeting for Share Consolidation and Capital Increase
6-K
Alps Group Inc Reports Fiscal Year 2026 Financial Results and Business Update
6-K
Alps Group Inc Launches Patient-Derived Organoid (PDO) Program to Advance Precision Oncology in Southeast Asia
6-K
Alps Group Inc Subsidiary MyGenome Receives MS ISO 15189:2022 Accreditation for Whole Genome Sequencing
Prospectus
TYPE
HEADLINE
FILED AT
424B3
SHARE RESALE REGISTRATION | Shares: 5,725,546
425
Form 425 - Prospectuses and communications, business combinations
